PharmaTher: 3D-printed drugs in North America
PharmaTher has obtained exclusive rights for North America to the CraftMake 3D drug printing platform, aiming for a distributed on-demand production network with up to 50 installations in 12 months among pharmacies, hospitals, and manufacturers.











